SNT 7.50% 4.3¢ syntara limited

Even Nova Quest didn't invest $40m into PXS, still shouldn't...

  1. 34,340 Posts.
    lightbulb Created with Sketch. 9122
    Even Nova Quest didn't invest $40m into PXS, still shouldn't lose 75% in two month time for the delay of FDA approval.

    QRX lost 69% on delay of FDA approval, fell from $1.70 to 50c, now recover to over $1.1, highest hit $1.37.

    PXS, positive things are still have plenty of cash and another bigger drug in Phase III
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.